Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential
Obesity Reviews · 2025-07 · 26 (7)
DOI: 10.1111/obr.13912 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, 2025-03. Verfasst von Zhongwen Qi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Gerontology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Heart Failure, Adipose Tissue, Pericardium, Stroke Volume. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, Evidence-based research project at Xiyuan Hospital, China Academy of Chinese Medical Sciences, National Natural Science Foundation of China.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
With the evolving landscape of diseases, heart failure with preserved ejection fraction (HFpEF) now encompasses more than half of all heart failure patients. This condition is clinically diverse, involving multiple organ systems and often occurring alongside the aging process. To deeply investigate the common pathogenesis of HFpEF and to explore new therapeutic approaches is of great significance for the treatment of HFpEF. Epicardial adipose tissue (EAT) is not only a dynamic organ with biological functions but also physically adjacent to the myocardium and coronary arteries, endowing it with unique properties as a visceral fat depot. During pathology, EAT can secrete adipocytokines via paracrine mechanisms, establishing direct communication with the heart and vascular, thereby impacting cardiac function. This review aims to elucidate the intricate relationship between EAT and cardiac function in HFpEF, delineate the roles of adipocytes, macrophages, lymphocytes, and stem cells within EAT in HFpEF, and summarize the progress in research regarding drug therapies targeting EAT for HFpEF treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Gerontology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Postdoctoral Research Station of China Academy of Chinese Medical Sciences, Beijing, China.
- Key Laboratory of Combination of Disease and Syndrome to Prevent Vascular Aging, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Traditional Chinese Medicine Department, The Second Hospital of Tianjin Medical University, Tianjin, China.
- Medical Experiment Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Peking University Health Science Center, Beijing, China.
ORCID-Profile: Zhongwen Qi
Förderung
- China Postdoctoral Science Foundation
- Evidence-based research project at Xiyuan Hospital, China Academy of Chinese Medical Sciences
- National Natural Science Foundation of China
Zitieren
APA
Qi, Z., Wu, D., Yan, Z., Wang, Q., Li, Y., Zhao, J., & Xu, F. (2025). Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential. Obesity Reviews, 26(7). https://doi.org/10.1111/obr.13912
Vancouver
Qi Z, Wu D, Yan Z, Wang Q, Li Y, Zhao J, et al. Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential. Obesity Reviews. 2025;26(7). doi:10.1111/obr.13912
BibTeX
@article{Qi2025,
author = {Qi, Zhongwen and Wu, Dan and Yan, Zhipeng and Wang, Qing and Li, Yiming and Zhao, Junnan and Xu, Fengqin},
title = {Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential},
journal = {Obesity Reviews},
year = {2025},
volume = {26},
number = {7},
doi = {10.1111/obr.13912}
}
EUVIMED